CAR-NK cells are allogeneic effector cells that can be easily expanded and modified, which can enhance the universality and simplicity of treatment, and make up for the weakness of autoimmune cells in patients with advanced cancer. CAR-NK cells kill target cells through CAR-dependent and NK cell receptor-dependent mechanisms that have eliminated tumor cells positive for tumor-associated antigens or tumor cells expressing NK cell receptor ligands. Shenzhen Cell Valley will provide the whole process service from NK cell collection, transduction to amplification, and the efficiency of transduction of foreign genes can reach more than 50%, which can help customers accelerate the research process in the field of CAR-NK.
CAR-NK cells are allogeneic effector cells that can be easily expanded and modified, which can enhance the universality and simplicity of treatment, and make up for the weakness of autoimmune cells in patients with advanced cancer. Cell Valley provides R&D and outsourcing production services for CAR-NK cells with different targets.
Shenzhen Cell Valley Bio-pharmaceutical Co., Ltd. is a one-stop comprehensive outsourcing service providerfocusing on the cell and gene therapy industry in China, and also the only CRO / CDMO company with the industrial production of clinical grade retroviral carrier GMP. Shenzhen Cell Valley with standardized, industrialized production capabilities.It mainly includes production lines for CAR-T, CAR-NK, CAR-M, mesenchymal stem cells, and astrocytes, as well as several cell raw material production lines, including genetically engineered antibodies, cytokines, exosomes, and viral vectors.Which including retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated viral vectors, and also provides IIT and IND application support services.
Official WeChat Account 
.jpg "Adeno-associated virus vector")
